Sarepta Therapeutics, Inc. (SRPT)
NASDAQ·Healthcare·Biotechnology
$18.71
+4.17%
Mkt Cap $1.87B
Analyst Ratings
Buy
1
Hold
2
Sell
2
Price Target (71 analysts)
$21.60
Range $17.00 – $27.00
Implied Upside
+15.4%
Consensus $21.60 vs current $18.71
NASDAQ·Healthcare·Biotechnology
$18.71
+4.17%
Mkt Cap $1.87B
Buy
1
Hold
2
Sell
2
Price Target (71 analysts)
$21.60
Range $17.00 – $27.00
+15.4%
Consensus $21.60 vs current $18.71